Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.786
-0.052 (-6.16%)
Mar 5, 2026, 4:00 PM EST - Market closed
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$68,513
Profits / Employee
-$23,496
Market Cap
7.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| KALA BIO | 38 |
| Kiora Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
| PharmaCyte Biotech | 2 |
| Addex Therapeutics | 2 |
| Pulmatrix | 2 |
EVGN News
- 14 hours ago - Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 hours ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 23 hours ago - Evogene Earnings Review: Q4 Summary - Benzinga
- 23 hours ago - Evogene GAAP EPS of -$0.61, revenue of $0.31M - Seeking Alpha
- 23 hours ago - Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 1 day ago - An Overview of Evogene's Earnings - Benzinga
- 1 day ago - Evogene Q4 2025 Earnings Preview - Seeking Alpha
- 8 days ago - Evogene Releases CEO Letter to Shareholders - PRNewsWire